This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Walter Weber: Innovator in Pyridine Derivatives
Introduction: Walter Weber, a distinguished inventor based in Hofheim, Germany, has made significant contributions to the field of chemistry through his patented innovations. His focus on efficient synthesis processes has led to advancements in the preparation of pyridine-substituted amino ketal derivatives.
Latest Patents: Walter Weber holds a patent for a novel process aimed at preparing derivatives of 1-(pyridinyl)-1,1-dialkoxy-2-aminoethane. This patent details an efficient method to produce these compounds with high purity and yield, avoiding the isolation of acetylpyridine oxime, a critical safety concern when handled as a solid. The process is noted for its effectiveness in delivering essential derivatives crucial for various chemical applications.
Career Highlights: Walter Weber is currently employed at Aventis Pharma Deutschland GmbH, where he contributes his expertise to pharmaceutical innovations. His work is focused on enhancing the efficiency and safety of chemical processes, aligning with the company's commitment to advancing healthcare solutions.
Collaborations: Throughout his career, Walter has collaborated with esteemed colleagues, including Hans-Wolfram Flemming and Gerhard Korb. These partnerships have fostered an environment of innovation, allowing them to tackle complex challenges in organic and pharmaceutical chemistry.
Conclusion: Walter Weber's contributions to the field of chemistry, particularly through his patent for pyridine-substituted amino ketal derivatives, showcase his commitment to innovation and safety. As he continues to work at Aventis Pharma Deutschland GmbH, his efforts will undoubtedly pave the way for further advancements in chemical processes and pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
